BCM
AGN

Beryl Capital Management’s Allergan plc AGN Stock Holding History

Beryl Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-148,971
Closed -$26.4M – 76
2020
Q1 		$26.4M Sell
148,971
-261,453
-64% -$49.2M 5.57% 6
2019
Q4 		$78.5M Buy
410,424
+375,791
+1,085% +$67.8M 12.65% 1
2019
Q3 		$5.83M Buy
+34,633
New +$5.64M 1.5% 14

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Beryl Capital Management's AGN Position: Q2 2020 in Review

Beryl Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 148,971 shares — an estimated $26.4M sold.

Beryl Capital Management first reported a position in AGN in Q3 2019 and held it in 3 quarters. The position peaked at $78.5M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Beryl Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Beryl Capital Management sold 148,971 Allergan plc shares in Q2 2020, an estimated $26.4M.
  • Beryl Capital Management first reported a position in Allergan plc in Q3 2019 and held it in 3 quarters.
  • Beryl Capital Management's Allergan plc position peaked at $78.5M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Beryl Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.